SKI II [Ligand Id: 6041] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL1076555 |
|---|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| 5-LOX/Arachidonate 5-lipoxygenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL215] [GtoPdb: 1385] [UniProtKB: P09917] | ||||||||
| ChEMBL | Inhibition of 5-lipoxygenase in human PMNL using arachidonic acid as substrate preincubated for 15 mins before substrate addition measured after 10 mins | B | 6.15 | pIC50 | 700 | nM | IC50 | Eur J Med Chem (2014) 84: 302-311 [PMID:25036790] |
| ChEMBL | Inhibition of partially purified recombinant 5-lipoxygenase (unknown origin) using arachidonic acid as substrate preincubated for 15 mins before substrate addition measured after 10 mins by HPLC analysis | B | 7.52 | pIC50 | 30 | nM | IC50 | Eur J Med Chem (2014) 84: 302-311 [PMID:25036790] |
| Salivary alpha-amylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2478] [UniProtKB: P0DUB6] | ||||||||
| ChEMBL | Inhibition of human salivary alpha-amylase using GalG2CNP as substrate by UV-Vis spectrophotometric analysis | B | 2.98 | pIC50 | 1043000 | nM | IC50 | Bioorg Med Chem (2015) 23: 6725-6732 [PMID:26395057] |
| delta 4-desaturase, sphingolipid 1/Sphingolipid delta(4)-desaturase DES1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2021749] [GtoPdb: 2484] [UniProtKB: O15121] | ||||||||
| GtoPdb | - | - | 6.52 | pKi | 300 | nM | Ki | J Lipid Res (2014) 55: 1711-20 [PMID:24875537] |
| ChEMBL | Noncompetitive inhibition of DES1 in human HGC-27 cell lysates assessed as inhibition constant | B | 6.52 | pKi | 300 | nM | Ki | J Med Chem (2021) 64: 279-297 [PMID:33395289] |
| sphingosine kinase 1/Sphingosine kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4394] [GtoPdb: 2204] [UniProtKB: Q9NYA1] | ||||||||
| ChEMBL | Inhibition of human recombinant SphK1 expressed in Sf9 cells assessed as radiolabeled products using 5 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting | B | 4.77 | pKi | 17000 | nM | Ki | J Med Chem (2015) 58: 1879-1899 [PMID:25643074] |
| ChEMBL | Inhibition of recombinant human GST-tagged SphK1 using [3H]-sphingosine as substrate after 30 mins by scintillation counting method | B | 4.77 | pKi | 17000 | nM | Ki | Eur J Med Chem (2017) 139: 461-481 [PMID:28822281] |
| ChEMBL | Inhibition of SPHK1 (unknown origin) | B | 4.77 | pKi | 17000 | nM | Ki | Bioorg Med Chem (2016) 24: 3218-3230 [PMID:27255176] |
| ChEMBL | Inhibition of SphK1 (unknown origin) assessed as inhibition constant | B | 4.8 | pKi | 16000 | nM | Ki | Eur J Med Chem (2021) 213: 113164-113164 [PMID:33454547] |
| ChEMBL | Inhibition of SK1 (unknown origin) | B | 4.8 | pKi | 16000 | nM | Ki | J Med Chem (2016) 59: 965-984 [PMID:26780304] |
| ChEMBL | Inhibition of recombinant human SphK1 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]SIP production using D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method | B | 4.8 | pKi | 16000 | nM | Ki | Bioorg Med Chem (2021) 30: 115941-115941 [PMID:33385956] |
| ChEMBL | Binding affinity to Sphk1 (unknown origin) assessed as inhibition constant | B | 4.8 | pKi | 16000 | nM | Ki | Eur J Med Chem (2021) 210: 112953-112953 [PMID:33148490] |
| ChEMBL | Inhibition of SK1 (unknown origin) | B | 4.8 | pKi | 16000 | nM | Ki | J Med Chem (2021) 64: 279-297 [PMID:33395289] |
| ChEMBL | Inhibition of recombinant human SPHK1 expressed in Escherichia coli using [3-3H]sphingosine as substrate after 30 mins by scintillation counting | B | 4.8 | pKi | 16000 | nM | Ki | J Med Chem (2017) 60: 3933-3957 [PMID:28406646] |
| ChEMBL | Inhibition of full-length SK1 (unknown origin) (2 to 384 residues) expressed in Escherichia coli using Sph as substrate by resorufin based fluorescence assay | B | 4.8 | pKi | 16000 | nM | Ki | J Med Chem (2019) 62: 3658-3676 [PMID:30889352] |
| GtoPdb | - | - | 4.8 | pKi | 16000 | nM | Ki | J Pharmacol Exp Ther (2010) 333: 129-39 [PMID:20061445] |
| ChEMBL | Inhibition of human recombinant SPHK1 expressed in baculovirus-infected Sf9 cells | B | 4.92 | pKi | 12000 | nM | Ki | J Med Chem (2011) 54: 3524-3548 [PMID:21495716] |
| ChEMBL | Inhibition of SPHK1 | B | 4.92 | pKi | 12000 | nM | Ki | J Med Chem (2011) 54: 3524-3548 [PMID:21495716] |
| ChEMBL | Inhibition of purified human SphK1 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting | B | 6.3 | pKi | 500 | nM | Ki | Bioorg Med Chem Lett (2013) 23: 4608-4616 [PMID:23845219] |
| ChEMBL | Inhibition of recombinant human SphK1 using NBD-sphingosine as substrate after 2 hrs in presence of ATP by HPLC method | B | 4.46 | pIC50 | 35000 | nM | IC50 | Bioorg Med Chem (2017) 25: 3046-3052 [PMID:28408190] |
| ChEMBL | Inhibition of SK1 (unknown origin) | B | 4.46 | pIC50 | 35000 | nM | IC50 | J Med Chem (2018) 61: 9811-9840 [PMID:29969256] |
| GtoPdb | Measured using a GST-hSPHK1 fusion protein | - | 6.3 | pIC50 | 500 | nM | IC50 | Cancer Res (2003) 63: 5962-9 [PMID:14522923] |
| ChEMBL | Non competitive inhibition of Sphk-(unknown origin) | B | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (2022) 65: 893-921 [PMID:33539089] |
| ChEMBL | Inhibition of SphK (unknown origin) | B | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (2022) 65: 893-921 [PMID:33539089] |
| ChEMBL | Inhibition of human Sphk1 (9 to 364 residues) | B | 6.3 | pIC50 | 500 | nM | IC50 | Eur J Med Chem (2020) 208: 112792-112792 [PMID:32949964] |
| sphingosine kinase 2/Sphingosine kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3023] [GtoPdb: 2205] [UniProtKB: Q9NRA0] | ||||||||
| ChEMBL | Inhibition of SPHK2 (unknown origin) | B | 4.3 | pKi | 50000 | nM | Ki | Bioorg Med Chem (2016) 24: 3218-3230 [PMID:27255176] |
| ChEMBL | Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting | B | 4.3 | pKi | 50000 | nM | Ki | J Med Chem (2015) 58: 1879-1899 [PMID:25643074] |
| ChEMBL | Inhibition of SphK2 (unknown origin) assessed as inhibition constant | B | 5.1 | pKi | 8000 | nM | Ki | Eur J Med Chem (2021) 213: 113164-113164 [PMID:33454547] |
| GtoPdb | - | - | 5.1 | pKi | 7900 | nM | Ki | PLoS ONE (2012) 7: e44543 [PMID:22970244] |
| ChEMBL | Inhibition of recombinant human SPHK2 expressed in Escherichia coli using [3-3H]sphingosine as substrate after 30 mins by scintillation counting | B | 5.1 | pKi | 7900 | nM | Ki | J Med Chem (2017) 60: 3933-3957 [PMID:28406646] |
| ChEMBL | Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method | B | 5.1 | pKi | 7900 | nM | Ki | Bioorg Med Chem (2021) 30: 115941-115941 [PMID:33385956] |
| ChEMBL | Binding affinity to Sphk2 (unknown origin) assessed as inhibition constant | B | 5.1 | pKi | 7900 | nM | Ki | Eur J Med Chem (2021) 210: 112953-112953 [PMID:33148490] |
| ChEMBL | Inhibition of SK2 (unknown origin) | B | 5.1 | pKi | 7900 | nM | Ki | J Med Chem (2021) 64: 279-297 [PMID:33395289] |
| ChEMBL | Inhibition of SK2 (unknown origin) | B | 5.1 | pKi | 7900 | nM | Ki | J Med Chem (2016) 59: 965-984 [PMID:26780304] |
| ChEMBL | Inhibition of SK2 (unknown origin) | B | 5.17 | pKi | 6700 | nM | Ki | J Med Chem (2019) 62: 3658-3676 [PMID:30889352] |
| ChEMBL | Inhibition of recombinant human SphK2 using NBD-sphingosine as substrate after 2 hrs in presence of ATP by HPLC method | B | 4.7 | pIC50 | 20000 | nM | IC50 | Bioorg Med Chem (2017) 25: 3046-3052 [PMID:28408190] |
| ChEMBL | Inhibition of SK2 (unknown origin) | B | 4.7 | pIC50 | 20000 | nM | IC50 | J Med Chem (2018) 61: 9811-9840 [PMID:29969256] |
| sphingosine kinase 2/Sphingosine kinase 2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075305] [GtoPdb: 2205] [UniProtKB: Q9JIA7] | ||||||||
| ChEMBL | Inhibition of mouse recombinant SPHK2 expressed in baculovirus-infected Sf9 cells | B | 4.48 | pKi | 33000 | nM | Ki | J Med Chem (2011) 54: 3524-3548 [PMID:21495716] |
| Transitional endoplasmic reticulum ATPase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075145] [UniProtKB: P55072] | ||||||||
| ChEMBL | Inhibition of VCP assessed as conversion of ATP to ADP by enzyme coupled glucokinase assay | B | 7.15 | pIC50 | 70 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 1677-1679 [PMID:20137940] |
| ChEMBL | Inhibition of VCP in human HeLa cells assessed as stabilization of ubiquitin-tagged luciferase after 24 hrs by reporter gene assay | B | 5.92 | pEC50 | <1200 | nM | EC50 | Bioorg Med Chem Lett (2010) 20: 1677-1679 [PMID:20137940] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
